Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. AssistIQ
AssistIQ Technologies Inc. is a Montreal-based healthcare technology company specializing in AI-driven solutions for surgical and procedural supply chain management. Their flagship product, AIQ Capture, utilizes computer vision to track real-time supply and implant usage in operating rooms, aiming to reduce waste, improve operational efficiency, and enhance revenue recovery for healthcare providers.
- Sector: Health Care
- Last known transaction date: Series A Venture, $11.5M, May 2025
- Why timing suggests a near-term transaction: A $11.5M Series A in May 2025 provides a lean 18–24 month runway for a healthcare AI company, where clinical validation, regulatory navigation, and enterprise hospital system sales cycles drive elevated capital consumption — placing AssistIQ in the active fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate platform adoption, measurable clinical outcomes, and the revenue traction that growth-stage healthcare technology investors require.
View all private company data in Dakota Marketplace.
2. Inven
Inven is a Finnish technology company founded in 2022 by former McKinsey and BCG consultants Niilo Pirttijärvi, Tommi Kupiainen, and Ekku Jokinen. The company offers an AI-native deal sourcing platform that analyzes over 21 million companies to help M&A professionals identify and evaluate private market opportunities more efficiently. Inven's platform continuously maps and analyzes a vast network of companies, providing predictive insights and uncovering hidden opportunities to streamline the deal sourcing process.
- Sector: Information Technology
- Last known transaction date: Series A Venture, $12.75M, May 2025
- Why timing suggests a near-term transaction: Inven's $12.75M Series A in May 2025 places the company roughly 18–24 months removed from its most recent financing by late 2026 to early 2027, aligning with the typical window when AI SaaS platforms begin preparing for a Series B. As platform adoption among M&A professionals, data coverage expansion, and recurring revenue growth progress, the company is likely to evaluate follow-on capital, strategic partnerships, or acquisition interest.
View all private company data in Dakota Marketplace.
3. Kyron.bio
Kyron.bio is a biotechnology company founded in 2022 and headquartered in Paris, France. The company specializes in glycan engineering to enhance therapeutic proteins, particularly antibodies, by precisely controlling their glycosylation patterns. This innovative approach aims to improve the safety and efficacy of biologic drugs. The leadership team includes Dr. Emilia McLaughlin, CEO and Founder, who holds a PhD from Institut Pasteur Paris; Dr. Marina Lochhead, Head of R&D, with a PostDoc from Institut Curie Paris; and Dr. Caroline Desmurget, Senior Scientist, formerly of Merck Switzerland.
- Sector: Health Care
- Last known funding round: Seed Venture, $6M, May 2025
- Why timing suggests a near-term transaction: Kyron.bio's $6M seed round announced in May 2025 places the company roughly 12–18 months removed from its most recent financing by late 2026, aligning with the typical window when preclinical-stage biotech companies begin preparing for their next raise. As glycan-engineering platform development, preclinical study results, and early biopharma partnerships progress, the company is likely to evaluate follow-on capital, strategic licensing agreements, or acquisition interest.
View all private company data in Dakota Marketplace.
4. Palla
Palla Financial Inc. is a financial technology company specializing in enabling instant peer-to-peer (P2P) payments globally. Their platform integrates with financial institutions and fintech applications to facilitate secure, real-time money transfers across over 180 countries, operating 24/7/365.
- Sector: Financials
- Last known funding round: Series A Venture, $14.5M, May 2025
- Why timing suggests a near-term transaction: A $14.5M Series A in May 2025 provides roughly 18–24 months of runway for a fintech company, where regulatory compliance, technology infrastructure, and customer acquisition costs drive steady capital consumption — placing Palla in the active fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate revenue scale, user growth, and the unit economics that growth-stage financial services investors require.
View all private company data in Dakota Marketplace.
5. Alrik
Alrik is an automated delivery platform tailored for suppliers and merchants in the construction industry. It offers a comprehensive solution to manage fleets, couriers, and supply chain operations, enabling businesses to enhance delivery efficiency and customer experience.
- Sector: Industrials
- Last known funding round: Seed Venture, $7.8M, May 2025
- Why timing suggests a near-term transaction: Alrik's $7.8M seed round announced in May 2025 places the company roughly 12–18 months removed from its most recent financing by late 2026, aligning with the typical timing for seed-stage logistics platforms preparing for their next growth round. As European market expansion, enterprise client adoption, and platform enhancements progress, the company is likely to evaluate follow-on capital, strategic partnerships, or acquisition interest.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
